Net sales reached $6.1 billion, a 13.8% increase compared to $5.3 billion in Q1 2025. Organic sales growth was 12.3%, reflecting volume growth across all three business segments. Net income attributable to common stockholders rose to $153.8 million, up from $104.0 million in the prior year period. Diluted earnings per share (EPS) increased to $3.11 from $2.10 in Q1 2025. Adjusted EBITDA grew 25.1% year-over-year to $388.8 million. The company issued $1.5 billion in new senior notes to refinance debt due in 2028.